- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Computational Approaches in Drug Discovery and Design: From Molecular Modeling to Translational Applications
This special issue belongs to the section “Molecular Informatics“.
Special Issue Information
Dear Colleagues,
This Special Issue aims to highlight recent advances in computational methods that are transforming modern drug discovery and development. Emphasis will be placed on the integration of molecular modeling, AI-driven drug design, molecular dynamics simulations, quantum chemical approaches, structure-based and ligand-based drug design, as well as multi-scale modeling in predicting pharmacokinetics, toxicity, and efficacy.
Topics of interest include but are not limited to the following: in silico screening and optimisation of drug candidates; molecular docking and molecular dynamics simulations in target interaction studies; AI and machine learning in drug repurposing and de novo drug design; computational toxicology and safety prediction; pharmacophore modeling and virtual screening workflows; integration of omics data with modeling tools for personalised therapeutics; modeling of nanodrug behaviour and interactions at the cellular level; predictive models for ADME/T properties; and drug–drug interactions.
This Issue will serve as a platform for interdisciplinary research, bridging computational science, chemistry, pharmacology, and systems biology, with the goal of accelerating and improving the drug development pipeline.
Dr. Przemysław Czeleń
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- computational drug discovery
- molecular modeling
- AI-driven drug design
- molecular dynamics simulations
- quantum chemistry
- structure-based drug design
- machine learning in pharmacology
- virtual screening and docking
- ADMET prediction
- personalized medicine modeling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

